input_muta,unp_canonical_muta,uniprot_id,Core,Surface,Helix,Sheet,Loop,PTM,PTM-4Å,PTM-8Å,AlloSite,PPI-BS,PLI-BS,PNI-BS,IDReg,SLiM,DomReg,Aliphatic,Aromatic,PosCharge,NegCharge,Neutral,Special,Charge-0,Charge-1,Charge-2,Size-0,Size-1,Size-2,$\Delta\Delta G_{fold}$,$\Delta\Delta G_{bind}$,Functional class,Subcellular location,Cancer signaling pathway,KEGG pathway,Specific domain
P21359-2|R1276P,P21359_R1276P,P21359,0,0,0,0,0,0,0,0,1,1,1,0,1,0,1,0,0,1,0,0,0,0,1,0,0,0,1,0.0,1.25,protein-binding activity modulator,Mitochondria,0,KEGG_MAPK_SIGNALING_PATHWAY,RasGAP_dom
P04637|H178Q,P04637_H178Q,P04637,0,1,1,0,0,0,0,1,1,1,1,0,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0.24,0.22,gene-specific transcriptional regulator,Nucleoplasm|Cytosol|Vesicles,Transforming growth factor beta (TGF-beta) receptor|Oncostatin-M (OSM),KEGG_MAPK_SIGNALING_PATHWAY|KEGG_CELL_CYCLE|KEGG_P53_SIGNALING_PATHWAY|KEGG_APOPTOSIS|KEGG_WNT_SIGNALING_PATHWAY|KEGG_NEUROTROPHIN_SIGNALING_PATHWAY|KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS|KEGG_HUNTINGTONS_DISEASE|KEGG_PATHWAYS_IN_CANCER|KEGG_COLORECTAL_CANCER|KEGG_PANCREATIC_CANCER|KEGG_ENDOMETRIAL_CANCER|KEGG_GLIOMA|KEGG_PROSTATE_CANCER|KEGG_THYROID_CANCER|KEGG_BASAL_CELL_CARCINOMA|KEGG_MELANOMA|KEGG_BLADDER_CANCER|KEGG_CHRONIC_MYELOID_LEUKEMIA|KEGG_SMALL_CELL_LUNG_CANCER|KEGG_NON_SMALL_CELL_LUNG_CANCER,p53_DNA-bd
P27986|G376R,P27986_G376R,P27986,0,1,0,0,1,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,1,0,1,0,0,0,1,0.68,0.0,protein-binding activity modulator,Cytosol,Transforming growth factor beta (TGF-beta) receptor|Prolactin|Leptin|Interleukin-9 (IL-9)|Interleukin-5 (IL-5)|Interleukin-2 (IL-2)|Thyroid-stimulating hormone (TSH)|T Cell Receptor (TCR)|Oncostatin-M (OSM)|Kit Receptor|Interleukin-7 (IL-7)|Interleukin-4 (IL-4)|Interleukin-1 (IL-1)|Brain-derived neurotrophic factor (BDNF)|Alpha6 Beta4 Integrin|Receptor activator of nuclear factor kappa-B ligand (RANKL)|Notch|Interleukin-11 (IL-11)|Interleukin-6 (IL-6)|Interleukin-3 (IL-3)|Epidermal growth factor receptor (EGFR)|B cell receptor (BCR)|Androgen receptor (AR),KEGG_ERBB_SIGNALING_PATHWAY|KEGG_CHEMOKINE_SIGNALING_PATHWAY|KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM|KEGG_MTOR_SIGNALING_PATHWAY|KEGG_APOPTOSIS|KEGG_VEGF_SIGNALING_PATHWAY|KEGG_FOCAL_ADHESION|KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY|KEGG_JAK_STAT_SIGNALING_PATHWAY|KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY|KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY|KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY|KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY|KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS|KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION|KEGG_NEUROTROPHIN_SIGNALING_PATHWAY|KEGG_REGULATION_OF_ACTIN_CYTOSKELETON|KEGG_INSULIN_SIGNALING_PATHWAY|KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION|KEGG_TYPE_II_DIABETES_MELLITUS|KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION|KEGG_PATHWAYS_IN_CANCER|KEGG_COLORECTAL_CANCER|KEGG_RENAL_CELL_CARCINOMA|KEGG_PANCREATIC_CANCER|KEGG_ENDOMETRIAL_CANCER|KEGG_GLIOMA|KEGG_PROSTATE_CANCER|KEGG_MELANOMA|KEGG_CHRONIC_MYELOID_LEUKEMIA|KEGG_ACUTE_MYELOID_LEUKEMIA|KEGG_SMALL_CELL_LUNG_CANCER|KEGG_NON_SMALL_CELL_LUNG_CANCER,SH2
P04637|I251S,P04637_I251S,P04637,1,0,0,1,0,0,0,1,1,0,1,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,1,2.59,1.19,gene-specific transcriptional regulator,Nucleoplasm|Cytosol|Vesicles,Transforming growth factor beta (TGF-beta) receptor|Oncostatin-M (OSM),KEGG_MAPK_SIGNALING_PATHWAY|KEGG_CELL_CYCLE|KEGG_P53_SIGNALING_PATHWAY|KEGG_APOPTOSIS|KEGG_WNT_SIGNALING_PATHWAY|KEGG_NEUROTROPHIN_SIGNALING_PATHWAY|KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS|KEGG_HUNTINGTONS_DISEASE|KEGG_PATHWAYS_IN_CANCER|KEGG_COLORECTAL_CANCER|KEGG_PANCREATIC_CANCER|KEGG_ENDOMETRIAL_CANCER|KEGG_GLIOMA|KEGG_PROSTATE_CANCER|KEGG_THYROID_CANCER|KEGG_BASAL_CELL_CARCINOMA|KEGG_MELANOMA|KEGG_BLADDER_CANCER|KEGG_CHRONIC_MYELOID_LEUKEMIA|KEGG_SMALL_CELL_LUNG_CANCER|KEGG_NON_SMALL_CELL_LUNG_CANCER,p53_DNA-bd
